by Truveta staff | Aug 30, 2026 | Research
Authors: Jared Kern ⊕, Truveta, Inc, Bellevue, WA, Vidya Venkataraman, PhD ⊕, Truveta, Inc, Bellevue, WA, Esther Kim, PhD ⊕, Truveta, Inc, Bellevue, WA, Joud Roufael, MPH ⊕, Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕, Truveta, Inc, Bellevue, WA, Amy Wu ⊕, Truveta,...
by Truveta staff | Aug 30, 2026 | Research
Authors: Mantas Dmukauskas , PhD ⊕,Truveta, Inc, Bellevue, WA, Puja Rao, MPH ⊕, Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕, Truveta, Inc, Bellevue, WA, Joud Rafael, MPH ⊕, Truveta, Inc, Bellevue, WA, Jared Kearn ⊕, Truveta, Inc, Bellevue, WA, Nadia...
by Truveta staff | Aug 30, 2026 | Research
Authors: Amy Sullivan, MS ⊕, Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕, Truveta, Inc, Bellevue, WA, Jared Kern ⊕, Truveta, Inc, Bellevue, WA, Joud Roufael, MPH ⊕, Truveta, Inc, Bellevue, WA, Sarah Eng, MPH ⊕, Truveta, Inc, Bellevue, WA, Puja Rao, MPH ⊕,...
by Truveta staff | Aug 30, 2026 | Research
Authors: Joanne Wu ⊕,Pfizer, Inc, New York, NY, Sampada Gandi, MPH ⊕, Pfizer, Inc, New York, NY, Jared Kearn ⊕, Truveta, Inc, Bellevue, WA, Maria Maddalena Lino ⊕, Pfizer, Inc, New York, NY, Joe Engeda ⊕, Truveta, Inc, Bellevue, WA, Michelle R Iannacone ⊕ Pfizer,...
by Truveta Research | Aug 25, 2026 | Featured research, Research
July 2026 marked the largest month-to-month increase in GLP-1 prescribing among adults aged 65 years and older observed during the study period. AOM tirzepatide and AOM semaglutide showed the largest gains following launch of the Medicare GLP-1 Bridge, increasing...
by Truveta Research | Aug 10, 2026 | Research
Nearly one in five patients receiving a GLP-1 medication reported experiencing food insecurity within the past year. Food insecurity was more frequently reported among patients who were dispensed GLP-1 medications for diabetes (20.5%) than among those who were...
